Top Markets
#1 DogBull DogBull +108.22%
#2 Siacoin Siacoin +69.25%
#3 ADO Protocol ADO Protocol +58.39%
#4 MarsCoin MarsCoin +52.78%
#5 The Bitcoin Bull The Bitcoin Bull +32.54%
#6 AI XOVIA AI XOVIA +20.71%
#7 Ontology Gas Ontology Gas +19.90%
#8 Stratis Stratis +13.61%
#9 UnifAI Network UnifAI Network +12.65%
#10 Akedo Akedo +11.32%
Coin of the day
DogBull DogBull
Settings
Language
ENGLISH
Currency
USD
Theme
Shenzhen Bioeasy Biotechnology Co., Ltd. Shenzhen Bioeasy Biotechnology Co., Ltd.

Shenzhen Bioeasy Biotechnology Co., Ltd.

300942
Rank in Stocks #14730
Founded in 2007 and headquartered in Shenzhen, China, Shenzhen Bioeasy... Founded in 2007 and headquartered in Shenzhen, China, Shenzhen Bioeasy Biotechnology Co., Ltd. specializes in the development and commercialization of rapid testing instruments and reagents throughout the Chinese market. The company's comprehensive diagnostic equipment addresses a wide array of applications, spanning food and agricultural analysis, dairy, meat, and aquatic product testing, honey quality control, drug detection, public safety measures, and clinical diagnostics.
Share Price
$0.97671958
Market Cap
$395.65M
Change (1 day)
1.35%
Change (1 year)
-49.60%
Country
CN
Trade Shenzhen Bioeasy Biotechnology Co., Ltd. (300942)

Category

Healthcare
Revenue for Shenzhen Bioeasy Biotechnology Co., Ltd. (300942)
Revenue in Sep 2026 TTM: 0
According to Shenzhen Bioeasy Biotechnology Co., Ltd. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Shenzhen Bioeasy Biotechnology Co., Ltd. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH